Pregled bibliografske jedinice broj: 249969
Modification of the growth of MCa mammary carcinoma of CBA mouse by new adamantylpeptides
Modification of the growth of MCa mammary carcinoma of CBA mouse by new adamantylpeptides // International Journal of Oncology, 2 (1993), 607-612 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 249969 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Modification of the growth of MCa mammary carcinoma of CBA mouse by new adamantylpeptides
Autori
Sava, Gianni ; Pacor, S ; Vranešić, Branka ; Tomašić, Jelka ; Cocchietto, M
Izvornik
International Journal of Oncology (1019-6439) 2
(1993);
607-612
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
adamantylpeptides; MCa mammary carcinoma; metastasis; splenocyte activation
Sažetak
Two new adamantyl-peptides, D-(2-adamantyl)-glycyl-L-alanyl-D-isoglutamine hydrochloride (isomer 1) and L-(2-adamantyl)-glycyl-L-alanyl-D-isoglutamine hydrochloride (isomer 2) , were tested in the model of the MCa mammary carcinoma of CBA mouse. These compounds, particularly Isomer 2, showed to be more effective in reducing lung metastasis than primary tumor growth and to be active in conditions in which a low number of metastases are formed, a condition that is seen when the tumor is implanted s.c. or when its growth is slowed down by the lower inoculum size. The apparent lack of any correlation between the effect of Isomer 2 on tumor growth and metastasis formation and that of the response to Con A of the in vivo IL-2 selected spleen lymphocytes seems to suggest that the dose and treatment schedule chosen might not be the most appropriate.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Biologija, Temeljne medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus